slot demo SolarEdge shares fall on new CEO appointmentNotation Labs Secures $2 Million Credit Facility to Accelerate Production of QwelTM, a Cutting-Edge Lead Detection and Prevention SystemBOZEMAN, Mont. – Aurora, a self-driving trucking company, is making waves in Bozeman with its innovative technology and job creation. The company uses LIDAR, a tool that employs lasers and photonics to create a 3-D picture of the environment. Montana State University and Gallatin College have developed programs to educate students in photonics, preparing them for real-world applications. Some students have already secured positions with Aurora. Mayor Terry Cunningham of Bozeman emphasized the local impact, saying, "The genius folks who are creating those sparks and those innovations get to stay here in the place that they love, because of the innovations that they created. But also, for folks like Aurora who are creating businesses from that technology." Aurora has already introduced 70 tech jobs to the Bozeman area, with more on the horizon. Governor Greg Gianforte, who has a background in high tech, highlighted the state's role in fostering industry growth. "We've been reducing regulations. We've been reducing the tax burden. We've been making IT investments in education. And this really creates an environment where entrepreneurs can succeed in the private sector," he said. The new Aurora Bozeman location will function as a LIDAR testing and research facility, further contributing to the area's technological advancement.

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Southwest Airlines Co. - LUVNone

A try, a scrap with a star and a trophy from grandma: Sione’s incredible day

Notation Labs Secures $2 Million Credit Facility to Accelerate Production of QwelTM, a Cutting-Edge Lead Detection and Prevention System

Natixis Advisors LLC cut its stake in shares of United Therapeutics Co. ( NASDAQ:UTHR – Free Report ) by 4.2% in the 3rd quarter, Holdings Channel.com reports. The fund owned 17,011 shares of the biotechnology company’s stock after selling 739 shares during the period. Natixis Advisors LLC’s holdings in United Therapeutics were worth $6,096,000 as of its most recent SEC filing. Several other large investors have also recently modified their holdings of the stock. UniSuper Management Pty Ltd raised its holdings in United Therapeutics by 133.3% in the first quarter. UniSuper Management Pty Ltd now owns 700 shares of the biotechnology company’s stock worth $161,000 after buying an additional 400 shares during the last quarter. Canada Pension Plan Investment Board increased its position in shares of United Therapeutics by 567.2% during the first quarter. Canada Pension Plan Investment Board now owns 180,800 shares of the biotechnology company’s stock valued at $41,533,000 after acquiring an additional 153,700 shares in the last quarter. Bayesian Capital Management LP bought a new position in United Therapeutics in the 1st quarter valued at approximately $772,000. B. Riley Wealth Advisors Inc. bought a new position in United Therapeutics in the 1st quarter valued at approximately $219,000. Finally, California State Teachers Retirement System increased its holdings in shares of United Therapeutics by 2.1% in the 1st quarter. California State Teachers Retirement System now owns 74,773 shares of the biotechnology company’s stock worth $17,177,000 after purchasing an additional 1,525 shares in the last quarter. Hedge funds and other institutional investors own 94.08% of the company’s stock. Analyst Upgrades and Downgrades Several research firms recently commented on UTHR. Bank of America dropped their price objective on United Therapeutics from $303.00 to $280.00 and set an “underperform” rating on the stock in a research report on Thursday, August 1st. Wells Fargo & Company lifted their price target on shares of United Therapeutics from $350.00 to $380.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 20th. Argus raised their target price on shares of United Therapeutics from $360.00 to $400.00 and gave the stock a “buy” rating in a report on Thursday, October 31st. TD Cowen lifted their target price on shares of United Therapeutics from $350.00 to $400.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. Finally, StockNews.com raised United Therapeutics from a “buy” rating to a “strong-buy” rating in a report on Thursday, October 17th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $370.86. United Therapeutics Stock Up 1.5 % NASDAQ UTHR opened at $372.89 on Friday. United Therapeutics Co. has a 52 week low of $208.62 and a 52 week high of $417.82. The company has a market capitalization of $16.65 billion, a P/E ratio of 16.38, a price-to-earnings-growth ratio of 1.05 and a beta of 0.56. The stock’s 50-day moving average price is $365.06 and its 200-day moving average price is $331.37. United Therapeutics ( NASDAQ:UTHR – Get Free Report ) last issued its quarterly earnings results on Wednesday, October 30th. The biotechnology company reported $6.39 earnings per share for the quarter, beating the consensus estimate of $6.16 by $0.23. The business had revenue of $748.90 million for the quarter, compared to the consensus estimate of $722.62 million. United Therapeutics had a net margin of 40.31% and a return on equity of 19.22%. The company’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.38 earnings per share. Research analysts anticipate that United Therapeutics Co. will post 25.1 EPS for the current year. Insider Buying and Selling In other United Therapeutics news, CFO James Edgemond sold 7,802 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $345.41, for a total value of $2,694,888.82. Following the completion of the transaction, the chief financial officer now directly owns 3,210 shares in the company, valued at $1,108,766.10. This represents a 70.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website . Also, CEO Martine A. Rothblatt sold 269 shares of United Therapeutics stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $348.41, for a total transaction of $93,722.29. Following the sale, the chief executive officer now owns 130 shares in the company, valued at approximately $45,293.30. The trade was a 67.42 % decrease in their position. The disclosure for this sale can be found here . In the last quarter, insiders sold 117,496 shares of company stock valued at $43,765,042. Company insiders own 11.90% of the company’s stock. United Therapeutics Profile ( Free Report ) United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. Recommended Stories Want to see what other hedge funds are holding UTHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for United Therapeutics Co. ( NASDAQ:UTHR – Free Report ). Receive News & Ratings for United Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter .NEW YORK , Dec. 17, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of Southwest Airlines Co. (NYSE: LUV) in connection with Southwest Airlines' information technology infrastructure impacting the Company's business, operations, and stock price. If you currently own shares of Southwest Airlines stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=10716 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at case@rosenlegal.com . Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/ . The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40 th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com View original content to download multimedia: https://www.prnewswire.com/news-releases/rosen-law-firm-announces-investigation-of-breaches-of-fiduciary-duties-by-the-directors-and-officers-of-southwest-airlines-co--luv-302334153.html SOURCE THE ROSEN LAW FIRM, P. A.

Jennison Associates LLC Invests $703,000 in Leonardo DRS, Inc. (NASDAQ:DRS)COLUMBUS, Ohio (AP) — Will Howard passed for two touchdowns and rushed for another, TreVeyon Henderson ran for a score and No. 2 Ohio State beat previously undefeated No. 5 Indiana 38-15 on Saturday. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Bill Speltz: Don't blame the Montana defense for Saturday's Brawl debacle in Bozeman

Susquehanna Forecasts Strong Price Appreciation for Semtech (NASDAQ:SMTC) StockAs the out-of-home (OOH) industry enters an exciting period of growth and transformation , Mediaweek sits down with Christian Zavecz , chief strategy officer at QMS, to explore the opportunities, challenges, and innovations shaping the future of OOH advertising in Australia. 1. With the rise of 5G and connected cities, what new opportunities do you foresee for OOH campaigns in terms of creativity and audience engagement? As OOH assets gain greater bandwidth and connectivity, we expect to see increasing use of dynamic creative campaigns that update in real time. This includes support for full-motion video on select inventory, as well as more advanced programmatic formats that leverage connected data sources. We also foresee a future where a billboard is no longer just displaying a playlist of pre-defined images but can determine the best creative to display by leveraging data sources, AI, and IoT devices to optimise for the audience in real time. 2. How is QMS leveraging data and technology to enhance the targeting, interactivity, and effectiveness of OOH campaigns? Digital OOH is now a complex and highly sophisticated channel that requires a multi-dimensional approach to maximise outcomes. At QMS, we employ a multi-layered strategy that combines complementary data sources and tech solutions, enabling a holistic understanding of audiences, effective campaign optimisation, and seamless delivery at scale. A great example is our recent Paris 2024 Olympic and Paralympic Games partnership. This market-first initiative incorporated an optimised, data-informed network and was tech-enabled to deliver immediate sponsored content and creative dynamism to adjacent partner executions. In total, 81,478 dynamic pieces of content were served over the combined four-week Games period. 3. Programmatic OOH has been a growing trend. How do you see its adoption evolving in the Australian market next year, and what challenges remain? Programmatic OOH adoption will continue to grow as greater targeting specificity becomes available via both DSPs and media owners. This audience relevance allows marketers to complement traditional OOH campaigns by building frequency within key audience segments to increase ad favourability and prompt outcomes. Programmatic also reduces investment barriers for SME clients, broadening demand across a wider brand base. While adoption will increase, deeper measurement is required to demonstrate value and alleviate concerns around efficacy. The ability to holistically plan programmatic alongside traditional DOOH will further accelerate adoption. 4. Sustainability is a growing focus for brands. What steps is QMS taking to align OOH offerings with eco-conscious advertising? Sustainability remains a core priority. As brands place greater emphasis on environmental responsibility, it’s up to the media industry to support these efforts. The OOH industry recently united at the “Advancing Sustainability in OOH” event, where plans for industry-level action were shared. Key initiatives from QMS include foundational partnerships with AdNetZero ANZ, collaboration with Climate One to offer recyclable skin solutions for static OOH campaigns, and ensuring 100% of QMS-controlled assets are powered by GreenPower energy. Further initiatives to support customers’ climate-related disclosure reporting will be announced in the New Year. 5. What advancements do you foresee in measuring the effectiveness and ROI of OOH campaigns, particularly as brands demand more accountability? Technology continues to drive advancements in ROI measurement. Clients and agencies are demanding more outcome-based planning and investment solutions. The evolution in accuracy, affordability, and speed is driving the next wave of ROI capabilities, helping to deliver effectiveness and accountability. 6. How do you anticipate changing consumer behaviours – such as shifts in mobility and urbanisation – will influence OOH placement and strategy in 2025? While significant year-on-year shifts in consumer behaviour aren’t anticipated, one of the biggest milestones for 2025 will be the launch of MOVE 2.0. This next-generation measurement tool will deliver enhanced, granular audience insights, providing brands with greater confidence to invest in OOH. MOVE 2.0 will ensure campaigns target broadcast audiences through impactful touchpoints that influence a broad range of consumers. 7. Looking ahead, what excites you most about the OOH industry in 2025 and beyond? It’s an exciting time for the industry. The continued growth and evolution of capabilities are expanding the role digital OOH plays in client communication strategies. A key example is the global-first OOH study we launched in partnership with Amplified Intelligence, which investigates the link between human attention in OOH advertising and essential brand metrics. This study will continue into 2025, expanding subject matter and delivering even greater insights into attention in OOH. The DOOH landscape will also continue to grow, with more formats, locations, and screens becoming available to advertisers. However, premium, high-impact assets and the influence they deliver will prove more important than ever. Clients who embrace multi-dimensional approaches to their DOOH campaigns will unlock greater value from the medium, drive competitive advantage, and, most importantly, deliver favourable outcomes. Keep on top of the most important media, marketing, and agency news each day with the Mediaweek Morning Report – delivered for free every morning to your inbox.

With Frank Bisignano preparing his exit, who could be Fiserv's next CEO?

Two Colorado senators are expected to resign, prompting calls for vacancy reform

TikTok files legal challenge of federal government's shutdown order

SpaceX’s Falcon 9 Rocket Delivers 20 Starlink Satellites Into Orbit From California, Elon Musk Reacts

Suspect in the killing of UnitedHealthcare’s CEO struggles, shouts while entering courthouse ALTOONA, Pa. (AP) — The suspect in the killing of UnitedHealthcare’s CEO struggled with deputies and shouted while arriving for a court appearance in Pennsylvania a day after he was arrested at a McDonald’s and charged with murder. Luigi Nicholas Mangione emerged from a patrol car, spun toward reporters and shouted something partly unintelligible while deputies pushed him inside Tuesday. At the brief hearing, the defense lawyer informed the court that Mangione would not waive extradition to New York but instead wants a hearing on the issue. Mangione was denied bail. Brian Thompson, who led the United States’ largest medical insurance company, was killed last Wednesday as he walked alone to a Manhattan hotel for an investor conference. From wealth and success to murder suspect, the life of Luigi Mangione took a hard turn Luigi Nicholas Mangione was apparently living a charmed one: the grandson of a wealthy real estate developer, valedictorian of his elite Baltimore prep school and with degrees from one of the nation’s top private universities. Friends at an exclusive co-living space at the edge of touristy Waikiki in Hawaii where the 26-year-od Mangione once lived widely considered him a “great guy.” Pictures on his social media accounts show a fit, smiling, handsome young man on beaches and at parties. Now, investigators are working to piece together why Mangione diverged from a path of seeming success to make the violent and radical decision to gun down UnitedHealthcare CEO Brian Thompson in a brazen attack on a Manhattan street. Key details about the man accused of killing of UnitedHealthcare's CEO The 26-year-old man charged in last week’s killing of UnitedHealthcare’s CEO in New York City has appeared in a Pennsylvania courtroom. Luigi Nicholas Mangione was arrested Monday after a worker at a McDonald's in Altoona, Pennsylvania, notified police that he resembled the suspect in last Wednesday's killing of Brian Thompson. While being led into court to be arraigned Tuesday, Mangione shouted something that was partly unintelligible but referred to an “insult to the intelligence of the American people.” During the hearing in Hollidaysburg, Mangione was denied bail and his attorney said Mangione would not waive extradition. DA suggests unusual idea for halting Trump’s hush money case while upholding his conviction NEW YORK (AP) — Prosecutors are trying to preserve President-elect Donald Trump’s hush money conviction as he returns to office, and they're suggesting various ways forward. One novel notion is based on how some courts handle criminal cases when defendants die. In court papers made public on Tuesday, the Manhattan district attorney’s office proposed an array of options for keeping the historic conviction on the books. The proposals included freezing the case until he’s out of office, or agreeing that any future sentence wouldn’t include jail time. Another idea: closing the case with a notation that acknowledges his conviction but says that he was never sentenced and that his appeal wasn’t resolved because of presidential immunity. There's no immediate response from Trump's lawyers. Middle East latest: Israel bombs hundreds of sites across Syria as army pushes into border zone Israel says it bombed more than 350 military sites in Syria during the previous 48 hours, targeting “most of the strategic weapons stockpiles” in the country. Israeli Prime Minister Benjamin Netanyahu said the wave of strikes was necessary to keep the weapons from being used against Israel following the Syrian government’s stunning collapse. Israel also acknowledged its troops were pushing into a border buffer zone inside Syria, which was established after the 1973 Mideast war. However, Israel denied its forces were advancing Tuesday toward the Syrian capital of Damascus. Life in the capital was slowly returning to normal. People celebrated for a third day in a main square, and shops and banks reopened. Donald Trump is returning to the world stage. So is his trolling NEW YORK (AP) — President-elect Donald Trump’s recent dinner with Canadian Prime Minister Justin Trudeau and his visit to Paris for the reopening of the Notre Dame Cathedral were not just exercises in policy and diplomacy. For Trump, they were also prime trolling opportunities. Throughout his first term in the White House and his recent campaign to return there, the Republican has dished out provocative, antagonizing and mocking statements. Now that’s he’s preparing to return to the Oval Office, Trump is back at it, and his trolling is attracting more attention — and eyerolls. Report on attempts to kill Trump urges Secret Service to limit protection of foreign leaders WASHINGTON (AP) — A congressional task force looking into the assassination attempts against Donald Trump during his presidential campaign is recommending changes to the Secret Service. These include protecting fewer foreign leaders during the height of the election season and considering moving the agency out of the Department of Homeland Security. The 180-page report was released Tuesday. It constitutes one of the most detailed looks so far into the July 13 assassination attempt against Trump during a campaign rally in Pennsylvania and a second one in Florida two months later. South Korea's ex-defense minister is formally arrested over brief imposition of martial law SEOUL, South Korea (AP) — South Korea's previous defense minister has been formally arrested over his alleged collusion with President Yoon Suk Yeol and others in imposing martial law last week. Kim Yong Hyun resigned last week and has been detained since Sunday. He is the first person arrested in the case. Prosecutors have up to 20 days to determine whether to indict him. A conviction on the charge of playing a key role in rebellion carries the maximum death sentence. Kim is accused of recommending martial law to Yoon and sending troops to the National Assembly to block lawmakers from voting on it. Homes burn as wind-driven wildfire prompts evacuations in Malibu, California MALIBU, Calif. (AP) — Thousands of Southern California residents are under evacuation orders and warnings as firefighters battle a wind-driven wildfire in Malibu. The flames burned near seaside mansions and Pepperdine University, where students sheltering at the school’s library on Monday night watched as the blaze intensified. Officials on Tuesday said a “minimal number” of homes burned, but the exact amount wasn’t immediately known. More than 8,100 homes and other structures are under threat, including more than 2,000 where residents have been ordered to evacuate. Pepperdine University on Tuesday morning said the worst of the fire has pushed past campus. It was not immediately known how the blaze started. More beans and less red meat: Nutritionists weigh in on US dietary guidelines Americans should eat more beans, peas and lentils and cut back on red and processed meats and starchy vegetables. That's advice from a panel of expert nutritionists charged with counseling the U.S. government about the next edition of the dietary guidelines. The panel did not weigh in on the growing role of ultraprocessed foods that have been linked to health problems or alcohol use. But they did say people should continue to limit added sugars, sodium and saturated fat in pursuit of a healthy diet. Tuesday’s recommendations now go to federal officials, who will draft the final guidance set for release next year.